Member News

Healthcare efficiency: AI technology to reduce hospital readmissions

11 May 2020 Monash University researchers are using Artificial Intelligence (AI) to better understand the cause of hospital readmissions, in turn improving health outcomes and reducing the financial burden on the health system. In the biggest study of…

Australian Medtech Startup is Using AI to Help Newborns in Intensive Care

6 May 2020 This article has been shared from Hive Life and is written by Stephanie H. Read the full original article here.  Umbilical venous catheterisation is an emergency procedure performed on premature and critically ill newborns who…

CE mark for Trajan’s hemaPEN® blood microsampling device, now available for diagnostic use across EU and UK

7 May 2020 Trajan Scientific and Medical (Trajan) has declared hemaPEN® compliance with EU IVD Directive 98/79/EC, and its release for in vitro diagnostic use in the EU and UK. This follows the hemaPEN’s recent addition to the…

Certara & DMTC Collaborate to Study Using Chloroquine in Healthcare Workers at Risk for COVID-19

7 May 2020         Certara®, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical countermeasure capabilities, have entered into a…

Cynata Receives Ethics Approval to Commence Clinical Trial in COVID-19 and Clinical Development Update

8 May 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received ethics committee approval to commence a clinical trial to investigate early efficacy of Cynata’s proprietary CymerusTM…

Florey researchers to pursue first-in-clinic treatment for severe infant epilepsy

8 May 2020 Researchers at the Florey, in collaboration with the University of Melbourne, will pursue a potentially life-changing precision medicine treatment for children with severe forms of epilepsy, thanks to a new multi-year grant awarded from the…

AdAlta update: Dr Tim Oldham interviewed by Pitt Street Research

8 May, 2020 Our CEO, Dr Tim Oldham recently sat down with Stuart Roberts of Pitt Street research to talk about AdAlta’s growth strategy and upcoming Phase 1 clinical trials of lead candidate, AD-214. In the interview, Dr…

Killing ‘sleeper cells’ may enhance breast cancer therapy

7 May 2020 The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer – the most common form of breast cancer in Australia – according to preclinical studies led by Walter and Eliza…

Sienna enters New Zealand market with its hTERT IVD

6 May 2020 Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Scientle Innovations (“Scientle”) as its exclusive distributor in New Zealand. The distribution agreement provides Scientle with the right to…

CSL Behring Australia Commences Development of Treatment for Serious Cases of COVID-19

6 May 2020 CSL Behring Australia, a subsidiary of CSL Limited, today announced that it will begin immediate onshore development of an anti-SARS-CoV-2 plasma product with the potential to treat people with serious complications of COVID-19, particularly those…

Over $33 million to boost genomics research into cancers and to combat children’s diseases

6 May 2020 Via the Hon Greg Hunt MP The Morrison Government has awarded over $33 million to Australia’s best and brightest researchers to combat high mortality and low survivability cancers and diseases, improve paediatric acute care using…

10M grant enables MCRI’s BCG vaccine trial to expand internationally, enrol 10,000 healthcare workers

5 May 2020 An A$10 million grant from the Bill & Melinda Gates Foundation will allow the Murdoch Children’s Research Institute’s (MCRI) clinical trial of the BCG vaccine against COVID-19 to extend to 10,000 healthcare workers across Australia, Spain and The Netherlands.…

Home

News & opinion

Member Directory

Events